Sutton Wealth Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,955
Closed -$11.1K 1341
2021
Q2
$11.1K Hold
2,955
﹤0.01% 885
2021
Q1
$9.63K Hold
2,955
﹤0.01% 890
2020
Q4
$10.1K Hold
2,955
﹤0.01% 802
2020
Q3
$12.1K Hold
2,955
0.01% 685
2020
Q2
$9.99K Buy
2,955
+946
+47% +$2.76K 0.01% 707
2020
Q1
$4.68K Sell
2,009
-674
-25% -$1.84K ﹤0.01% 836
2019
Q4
$9.77K Hold
2,683
0.01% 826
2019
Q3
$22.3K Hold
2,683
0.01% 549
2019
Q2
$23.1K Hold
2,683
0.01% 524
2019
Q1
$28.7K Hold
2,683
0.02% 461
2018
Q4
$23.5K Hold
2,683
0.02% 474
2018
Q3
$45.1K Hold
2,683
0.03% 312
2018
Q2
$56.2K Hold
2,683
0.04% 263
2018
Q1
$43.2K Sell
2,683
-24
-0.9% -$475 0.03% 310
2017
Q4
$51.3K Sell
2,707
-301
-10% -$5.45K 0.04% 269
2017
Q3
$42.3K Hold
3,008
0.03% 307
2017
Q2
$22.4K Hold
3,008
0.02% 477
2017
Q1
$19.6K Hold
3,008
0.02% 526
2016
Q4
$13.3K Buy
+3,008
New +$12.6K 0.01% 616
2016
Q3
Sell
-993
Closed -$6.52K 1070
2016
Q2
$6.52K Hold
993
0.01% 728
2016
Q1
$6.32K Buy
+993
New +$5.09K 0.01% 695

Other funds holding SPPI

Sutton Wealth Advisors's SPPI Position: Q3 2021 in Review

Sutton Wealth Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2021, closing a stake of 2,955 shares — an estimated $11.1K sold.

Sutton Wealth Advisors first reported a position in SPPI in Q1 2016 and held it in 21 quarters. The position peaked at $56.2K in Q2 2018. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

  • Sutton Wealth Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Sutton Wealth Advisors sold 2,955 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $11.1K.
  • Sutton Wealth Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 21 quarters.
  • Sutton Wealth Advisors's Spectrum Pharmaceuticals Inc position peaked at $56.2K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Sutton Wealth Advisors's 13F filing for Q3 2021, filed 7 Nov 2023.